Public Company

Domestic passenger car sales jump 40% in Dec

Domestic passenger car sales jumped by 40.27 per cent to 1,15,268 units in December last year. - Total auto sales jump 68% to 1 mn units in Dec - Ku Klux Klan cartoon in Indian paper angers Australia - Race to lower car loan rate hots up - Subir Roy: An unbearable greyness">Subir Roy: An unbearable greyness - Ghosn overruling electric engineers - ICICI, Axis cut car loan rates Total passenger car sales were 82,174 units in the same month 2008. Motorcycle sales were up by 76.70 per cent at 5,92,596 units in last month compared to 3,35,370 units in the year-ago month, Society of Indian Automobile Manufacturers (SIAM) said at the 10th Auto Expo here. Total two-wheeler sales rose to 7,67,796 units in December 2009 from 4,60,852 units in the corresponding month in 2008, a growth of 66.60 per cent, SIAM said. The sale of commercial vehicles jumped by nearly three-fold to 48,614 units in the month compared to 17,897 units in the same month previous year, it added. The total auto sales were 10,00,500 units in December against 5,97,241 units in the same month in 2008.

car rental commented:

I like the post for giving the relevant information and best thing is that I agree with them at majority of factors they mentioned in the topic

15.03.2012


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Exports down by 29.2%; imports 39.2% in May
Merchandise exports contracted for the eighth consecutive month.
Popular Articles

Ispat Ind to repay Rs 800-cr loan
The Mittal brothers-led Ispat Industries plans to repay Rs 800 crore of debt in the next financial year to evade the risk of conversion of a part of its debt into equity by creditors. The company has total debt of Rs 7,000 crore lent by 14 creditors, who have got shareholders’ approval to convert a part of this into equity in case of default.

Top drug firms take in-licensing route to up sales
Leading Indian drug majors, such as Ranbaxy Laboratories, Dr Reddy’s Laboratories, Piramal Healthcare and Wockhardt, are in-licensing popular products from overseas drug makers to boost their domestic sales. They introduce the in-licensed drugs — which are mostly in the premium skin care segment — on payment of an upfront fee to the brand owners, who also get a share of the sales revenue.